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ABSTRACT
A growing number of progressive heredodegenerative
conditions mimic the presentation of Huntington’s
disease (HD). Differentiating among these HD-like
syndromes is necessary when a patient with a
combination of movement disorders, cognitive decline,
behavioural abnormalities and progressive disease course
proves negative to the genetic testing for HD causative
mutations, that is, IT15 gene trinucleotide-repeat
expansion. The differential diagnosis of HD-like
syndromes is complex and may lead to unnecessary and
costly investigations. We propose here a guide to this
differential diagnosis focusing on a limited number of
clinical features (‘red ﬂags’) that can be identiﬁed
through accurate clinical examination, collection of
historical data and a few routine ancillary investigations.
These features include the ethnic background of the
patient, the involvement of the facio-bucco-lingual and
cervical district by the movement disorder, the co-
occurrence of cerebellar features and seizures, the
presence of peculiar gait patterns and eye movement
abnormalities, and an atypical progression of illness.
Additional help may derive from the cognitive–
behavioural presentation of the patient, as well as by a
restricted number of ancillary investigations, mainly MRI
and routine blood tests. These red ﬂags should be
constantly updated as the phenotypic characterisation
and identiﬁcation of more reliable diagnostic markers for
HD-like syndromes progress over the following years.
INTRODUCTION
Huntington’s disease (HD) is the most common
hereditary neurodegenerative illness with onset
before mid-life and a distinct phenotype charac-
terised by movement disorders (mainly chorea, dys-
tonia and Parkinsonism), incoordination, cognitive
deterioration and behavioural changes. Progressive
neural cell loss within cortico-striato-thalamo-
cortical circuits, predominantly in the neostriatum
(caudate and putamen), leads to this clinical
presentation.1
HD is a trinucleotide-repeat disorder with auto-
somal dominant mode of inheritance. The causative
mutation is a prolongation (above 35 repeats) of a
trinucleotide (CAG) stretch within the IT15 gene,
associated with full penetrance when this exceeds
40 and incomplete penetrance between 36 and 39.
As in several other trinucleotide-repeat disorders,
there is a strong association between repeat length
and age at disease onset, with higher repeat length
leading to earlier onset. Paternal transmission facili-
tates this anticipation phenomenon. Age at onset is
strongly linked to the clinical expression of both
motor and cognitive features of the disease.1
Juvenile HD (ie, with onset before age 20) is domi-
nated by a hypokinetic-rigid syndrome (Westphal
variant) and a more rapid course, whereas
adult-onset HD classically presents with a choreatic
syndrome and a less severe progression of motor
and non-motor features.1
An increasing number of progressive heredode-
generative illnesses may mimic the presentation of
HD. It has been estimated that between 1% and
7% of subjects with a HD-like syndrome do not
have HD.2 Given the relationship between motor
phenotype and age at onset in HD, these HD-like
syndromes are, with some exceptions, either dis-
eases manifesting with a predominantly choreatic
syndrome and onset in adulthood (online supple-
mentary table 1a) or diseases presenting with pre-
dominant dystonia and Parkinsonism and onset in
the ﬁrst 2 decades (online supplementary table 1b).
The comprehensive understanding of the phenom-
enology and diagnosis of progressive HD-like syn-
dromes is crucial for an efﬁcient and cost-effective
diagnostic work-up and guides further genetic
testing once the diagnosis of HD has been genetic-
ally excluded. This work-up may include thorough
clinical examination, neuropsychological and
neuropsychiatric assessment, metabolic screening,
imaging and electrophysiology.
To date, progressive hereditary HD-like syn-
dromes were classiﬁed mainly according to their
mode of inheritance. Although this criterion can be
very helpful in the presence of a well-established
family history, it may not be practically useful in
the numerous cases in which family history is
unavailable or inaccurate. In this review, we discuss
the differential diagnosis of HD focusing on a
restricted number of clinical features (‘red ﬂags’)
that might help clinicians to narrow the spectrum
of working diagnoses and improve efﬁciency and
cost-effectiveness of the diagnostic process.
ETHNICITY
HD and the majority of progressive HD-like syn-
dromes can be encountered in most geographical
areas and ethnic groups. There are, however, a few
important exceptions to consider in the differential
diagnosis.
Huntington’s disease-like 2 (HDL2) is an auto-
somal dominant disorder described exclusively in
families of Southern African origins, with the
exception of one Brazilian family of Spanish/
Portuguese ancestry. This condition accounts for
about 0.7% of all HD-like presentations. HDL2 is
caused by a CTG stretch in the JPH3 gene coding
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for junctophilin-3, leading to ubiquitin-immunoreactive intra-
nuclear inclusions in the cortex and neuronal loss in the stri-
atum and cortex. Unlike in HD, repeat expansions are more
unstable and the anticipation phenomenon is more likely when
the disorder is maternally inherited. HDL2 starts at the same
age as HD, but can present either in a Parkinsonian or in a chor-
eatic form.3 The choreatic form is strikingly similar to typical
adult-onset HD, although both can present with cognitive
deterioration, psychiatric features, eye movement abnormalities
and MRI changes highly similar to HD. Overall, HDL2 should
be suspected in every patient of South African ancestry with a
HD-like presentation, accounting for 24%–50% of these cases.3
A HD-like syndrome in patients of Japanese ethnicity should
raise the suspicion of dentato-rubro-pallido-luysian atrophy
(DRPLA), another autosomal dominant disorder (summarised in
detail below). In Japan, the prevalence of DRPLA is estimated
to be similar to the prevalence of HD. DRPLA has been
reported in non-Japanese patients, and a single haplotype has
been found in both Japanese and Caucasian patients, in line
with a common founder effect shared across ethnic groups.4
Other conditions entering the differential diagnosis with HD
could be more represented in some geographical areas than in
others. Neuroferritinopathy is an autosomal dominant disorder
presenting with progressive adult-onset chorea or dystonia ini-
tially affecting the limbs and mild cognitive deterioration.
Molecular genetic testing for the FTL gene, coding for the fer-
ritin light chain, conﬁrms this diagnosis.5 This disorder was ini-
tially described in Cumbria, a region in the northwest of
England.5 The majority of reported cases were originally from
this region. Additional families reported in France and an add-
itional North-American patient with German ancestry do not
exclude the possibility of a founder effect in northwestern
Europe.6 Other examples of ethnic segregation in HD-like syn-
dromes include spino-cerebellar ataxia 8, especially common in
Finland,7 and ataxia with oculomotor apraxia (AOA) type 2,
mainly seen in French–Canadian and Anglo-Norman
populations.8
BODY SITE DISTRIBUTION OF MOTOR SYMPTOMS
Most progressive HD-like syndromes display a generalised
movement disorder, involving in different combinations face,
neck, torso and limbs. A disabling involvement of the
facio-bucco-linguo-masticatory region should, however, lead the
clinician towards a few speciﬁc conditions.
HD-like syndromes presenting in adulthood with chorea or
other movement disorders, including dystonia and tics, with
marked involvement of the facio-bucco-linguo-masticatory
region comprise ‘neuroacanthocytosis syndromes’, mainly
chorea-acanthocytosis and McLeod syndrome. Chorea-acantho-
cytosis is an autosomal recessive disorder caused by mutations
in the VPS13A gene coding for chorein, a large protein impli-
cated in intracellular protein sorting. Facio-bucco-linguo-masti-
catory chorea, dystonia and dyskinesias are typically precipitated
by feeding, with tongue protrusion and self-mutilating tongue
and lip biting.9 These patients may also present with violent
neck spasms with sudden ﬂexion/extension that can lead to
characteristic head drop and head banging (see online supple-
mentary video 1).10 Vocalisations and dysarthria are also
present, whereas Parkinsonism is rare.10 The co-occurrence of
areﬂexia, weakness and muscle wasting, suggestive of concomi-
tant peripheral neuropathy and/or myopathy, may further help
in the diagnosis.11
McLeod syndrome is named after a Harvard medical student,
Hugh McLeod, who did not express the Kell antigen on
erythrocytes, as all affected male subjects with this condition. It
is an X linked recessive disorder, present in most geographical
regions, caused by different mutations in the XK gene.11
McLeod syndrome is a multi-system disorder, affecting basal
ganglia, muscles, peripheral nerves and myocardium.11 It pre-
sents with chorea that may involve the facio-buccal region and
vocalisations, but almost never with tongue or lip biting, dys-
phagia, or Parkinsonism;11 feeding dystonia has also been
reported.12 Importantly, 60% of patients develop a cardiomyop-
athy with atrial ﬁbrillation and risk of cardiac sudden death,
thus requiring periodical cardiac monitoring.
When the movement disorder is mainly characterised by early
dystonia or a hypokinetic-rigid syndrome with relevant
facio-bucco-lingual involvement, the main differential diagnosis
to consider is pantothenate kinase-associated neurodegeneration
(PKAN), an autosomal recessive disorder with a frequency of 1–
3 per million, caused by mutations of the PANK2 gene coding
for pantothenate kinase, an enzyme relevant to the synthesis of
coenzyme A from vitamin B5 and associated with lipid metabol-
ism.13 PKAN is also known as neurodegeneration with brain
iron accumulation type 1 (NBIA1). In almost 90% of cases, this
condition starts before the age of 6, with rapid progression
towards negative outcome within 10 years. PKAN presents with
generalised dystonia with buccofacial and lingual involvement,
often in the form of severe jaw opening dystonia, although not
speciﬁcally related to feeding as in chorea-acanthocytosis (online
supplementary video 2).14 Parkinsonism may be a presenting
symptom, and choreoathetosis, tics and pyramidal signs may
also occur. About a third of these patients develop retinitis pig-
mentosa. Sometimes, PKAN has later onset and less severe pres-
entation, with rigidity, focal arm dystonia or cognitive–
behavioural onset.14 A similar orofacial action-speciﬁc dystonia,
associated with speech and dysarthrophonia, is seen in other
forms of NBIA, including Kufor–Rakeb syndrome (autosomal
recessive illness caused by ATP13A2 mutations),15 aceruloplas-
minemia and neuroferritinopathy, although the last typically
presents in adulthood.5 Wilson’s disease (WD) may also present
with severe orofacial dystonia associated with Parkinsonism and
in the setting of a generalised dystonia, thus sometimes posing a
diagnostic challenge with HD. Finally, Lesch–Nyhan syndrome
can also manifest in the ﬁrst decade with severe action dystonia
and chorea, often involving the bucco-lingual region.16
ATAXIA
Under rare circumstances, HD patients may exhibit a mild
degree of cerebellar atrophy throughout disease progression.
Marked cerebellar involvement has been reported only very
rarely in juvenile HD. When present, cerebellar signs are gener-
ally very mild, and the occurrence of clinically more severe cere-
bellar dysfunction suggests alternative diagnoses.
Probably the most common HD-like syndrome in Caucasian
populations is spinocerebellar ataxia 17 (SCA17, also known as
HDL4). This accounts for 0.5%–1.8% of all HD-like syn-
dromes, and its age of onset is between 19 and 48 years, rarely
starting during childhood.2 Like HD, SCA17 is an autosomal
dominant trinucleotide-repeat disorder, in which the mutated
TBP gene encodes for the TATA-box binding protein, an import-
ant general transcription initiation factor. Intergenerational
instability, especially during paternal transmission, and anticipa-
tion have been recognised.17 Cerebellar ataxia is the most
common feature, but SCA17 may be very heterogeneous.
Dystonia and chorea are the two most frequent movement dis-
orders. When Parkinsonism is present, SCA17 may resemble
multiple system atrophy, although without clear autonomic
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dysfunction, and the dopamine transporter single-photon emis-
sion computer tomography (DatScan, GE Healthcare) may be
abnormal. Pyramidal signs occur in more than a third of cases.
Overall, in most families, a true HD-like presentation is
observed only in one or few affected members, although intrafa-
milial phenotypic homogeneity has been described.17
Another important HD-like syndrome with cerebellar involve-
ment is DRPLA. This is an autosomal dominant disease caused
by CAG-repeat expansion in the ATN1 gene coding for
atrophin-1.18 Like HD and SCA17, DRPLA shows the phenom-
enon of anticipation, and its typical age at onset is the third
decade. DRPLA presents with three main features, chorea, myo-
clonus and ataxia. The differential diagnosis with HD and neu-
roacanthocytosis syndromes can be very challenging, especially
when chorea is a predominant clinical feature (online supple-
mentary video 3). When myoclonus is the most disabling
symptom, generally this is associated with an earlier onset
(<20 years), and with the coexistence of severe progressive
myoclonic epilepsy and cognitive decline. When onset occurs
after the age of 40, cerebellar ataxia is usually the predominant
characteristic.18
Other ataxic syndromes may present rarely with choreatic
movements. Unlike in SCA17, chorea presenting in young
adults is very uncommon in other autosomal dominant SCAs.
Choreatic movements of the limbs are exceptional in SCA1 and
SCA2, and slower than in HD.19 20 Patients with SCA7, another
trinucleotide disorder involving the ATXN7 gene coding for
ataxin 7, may rarely manifest small choreatic movements in the
distal limbs or in the orofacial district. Rare chorea of the hands
has been described in SCA14 patients.21 Finally, a recent screen-
ing of Greek patients with HD phenocopies identiﬁed a
CTA*CAG-repeat expansion at the SCA8 locus, involving the
complementary base-pairs of the ATXN8OS and ATXN8 genes,
the clinical signiﬁcance of which is however still uncertain.22
Autosomal recessive ataxias may present with chorea, but gen-
erally onset is in the ﬁrst two decades. Friedreich ataxia (FA) is
by far the most common of these forms, occurring in about 1 in
50 000 individuals. FA is characterised by progressive trunk and
limb ataxia, absent lower limb reﬂexes, Babinski sign, dysarthria,
reduced vibratory sense and proprioception, visual problems,
scoliosis, pes cavus, and cardiomyopathy. Generalised chorea,
involving also the tongue and affecting gait and manual dexter-
ity, is a very rare manifestation, with onset in the second
decade.23 24 Apart from the earlier onset, the patients described
in these reports differed from typical HD patients in the associ-
ation with a marked scoliotic abnormality of the spine or with
hypertrophic cardiomyopathy, but cerebellar signs were minimal
or appeared much later in the course of illness.
Chorea, dystonia and hypomimia occur in 90% of patients
with ataxia-teleangiectasia (AT), starting in the ﬁrst decade and
showing a rapid course. AT is probably the most common form
of progressive cerebellar ataxia of early childhood.25 This is an
autosomal recessive disorder manifesting also with teleangiecta-
sias, immune defects and a predisposition to malignancy. In
some patients, the dystonic posturing of the hands in combin-
ation with interosseus muscular atrophy may cause characteristic
ﬂexion–extension contractures of the ﬁngers. Finally, an earlier
onset of dystonia and chorea has been reported in <15% of
patients with AOA type 1 and type 2.26 27
GAIT DISORDER
Gait examination can be very helpful to identify typical features
suggestive of HD-like syndromes. Indeed, most of these syn-
dromes manifest with different motor abnormalities, which may
be present in different combination and lead to peculiar gait.
The association of chorea and predominantly ataxic gait, with
widened base and difﬁculties performing the tandem gait, is an
aspeciﬁc feature of both autosomal dominant (SCAs, DRPLA)
and autosomal recessive ataxias (FA, AT, AOAs). In chorea-
acanthocytosis and McLeod syndrome, the co-occurrence of
limb chorea, dystonia and peripheral neuropathy contributes to
the peculiar gait and postural changes of these disorders.10 11
These are characterised by unsteadiness of stance and gait,
leading to frequent falls, and caused by impaired postural
reﬂexes, sudden knee buckling, and equinovarus foot deform-
ities secondary to dystonia and atrophy of peroneal muscles.
The occurrence of ﬂinging movements of arms and legs, pelvic
thrusts and violent trunk spasms further compromise the stabil-
ity of gait in these patients.
The coexistence of dystonia, rigidity, bradykinesia and spasti-
city typiﬁes the gait pattern in juvenile HD-like syndromes, for
example, PKAN, WD, PLA2G6-associated neurodegeneration
(PLAN), Kufor–Rakeb syndrome or the Parkinsonian form of
HDL2.3 13 15 Particularly, gait disturbance is a common present-
ing symptom in PKAN, originating from the combination of
lower limb rigidity, dystonic foot posturing in plantar ﬂexion
and inversion, and spasticity, as well as restricted visual ﬁeld in
those children with retinopathy. Marked freezing of gait has
also been described in most syndromes mimicking juvenile HD.
EYE MOVEMENT ABNORMALITIES
A detailed examination of ocular movements can be very
informative. HD patients manifest early abnormalities in initiat-
ing saccades, which progressively become slow and hypometric,
with superimposed dysfunctional gaze ﬁxation. In several pro-
gressive HD-like syndromes, primarily chorea-acanthocytosis,11
PKAN14 and WD,28 we ﬁnd similar changes. A supranuclear
gaze palsy with marked impairment of upgaze saccades, asso-
ciated with oculogyric dystonic spasms and L-dopa-responsive
akinetic-rigid Parkinsonism, is typical of patients with Kufor–
Rakeb syndrome.29 In chorea-acanthocytosis, fractionated sac-
cades and square-wave jerks are also found.30
HD can present also with a mild form of oculomotor apraxia,
which is, however, much more severe in AOA types 1 and 2 and
AT.25–27 When asked to look to one side, subjects with oculo-
motor apraxia turn their heads ﬁrst, with eye contraversion,
after which their eyes follow to the same side in several slow
saccades with head thrusts to the point that, when the head is
immobilised, eye movements are virtually impossible.
Finally, it is very important to point out that an early mani-
festation of ‘cerebellar’ eye movement abnormalities, for
example, dysmetric saccades, square-wave jerks, ocular ﬂutter,
saccadic pursuit and gaze-evoked nystagmus, is typical of the
most common spinocerebellar degenerative illnesses, and hence
very useful to differentiate HD particularly from SCA-17
and FA.
SEIZURES
In HD, seizures are present only in the juvenile variant, occur-
ring in 30%–50% of patients with onset before age 10. At dif-
ference, in a number of progressive HD-like syndromes seizures
are relatively common, presenting in 22% of SCA-17 cases,
60% of cases with chorea-acanthocytosis, 40% of cases with
McLeod syndrome31 and the majority of cases with
Huntington’s disease-like 1 (HDL1) syndrome, a prion disease
resembling adult-onset HD (detailed below). Seizures are the
initial manifestation in almost half of chorea-acanthocytosis
cases. Temporal lobe seizures, even simulating a familial
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temporal lobe epilepsy, are seen in chorea-acanthocytosis,
whereas they are mostly generalised in McLeod syndrome.31
Seizures are also a cardinal feature of DRPLA, present in virtu-
ally all cases with onset before the age of 20, less frequently
when onset is between ages 20 and 40, and rarely with onset
above the age of 40.18 Seizures in DRPLA can be tonic, clonic,
tonic-clonic, absences, atonic, and in the form of myoclonic epi-
lepsy, with or without a progressive myoclonic epilepsy pheno-
type. Epilepsy is rare in all the other HD-like syndromes.
SPEED OF PROGRESSION
The rate of progression of HD can vary considerably across sub-
jects, being, at least in part, related to age of onset and length of
trinucleotide-repeat expansion. HD-like syndromes with adult
onset may vary in their speed of progression. Importantly, some
conditions may progress more rapidly. Among the latter, HDL1,
a very rare autosomal dominant prion disease with onset in
early adulthood (third–fourth decades), should be kept in
account. HDL1 is caused by a 192-nucleotide insertion in a
region of the prion protein (PRNP) gene coding for an
octapeptide-repeat. HDL1 is recognised as the fourth genetic
prion disease phenotype, although not associated typically with
spongiform degeneration pathology, but with atrophy and prion
deposition within basal ganglia, frontal and temporal lobes, and
cerebellar cortex.32 Although this condition progresses more
slowly than other prion diseases, case series reported that most
subjects survive between 1 and 10 years from onset. Patients
develop prominent personality changes, cognitive decline,
chorea, rigidity, limb and truncal ataxia, dysarthria and seizures.
It is useful to remind that chorea may be a feature also of the
most common prion disease, that is, Creutzfeldt–Jakob
disease.33 Other forms characterised by higher speed of progres-
sion are HDL2, relentlessly leading to death within
10–20 years,3 and DRPLA, generally leading to death within
10–15 years.18
Like juvenile HD, HD-like syndromes with earlier onset pro-
gress rapidly. An outstanding exception is benign hereditary
chorea (BHC), which, unlike other HD-like syndromes with
onset in the ﬁrst 2 decades, is characterised by a non-progressive
or very slowly progressive course dominated by chorea. BHC is
now considered a genetically heterogeneous spectrum, ﬁrst
described as an early-onset form of chorea not associated with
intellectual deterioration. It is suspected in cases of focal or gen-
eralised chorea with autosomal dominant inheritance, and is
often described as socially embarrassing (online supplementary
video 4). Disease onset occurs in early infancy. A relevant pro-
portion of these cases bear mutations in the NKX2-1 gene
encoding for thyroid transcription factor-1 (TITF-1), which is a
very important transcription factor involved in the organogen-
esis of the brain, thyroid and lungs.34 An allelic disorder to
BHC presents with a more severe phenotype characterised by
choreoathetosis, congenital hypothyroidism and neonatal
respiratory distress, also referred to as ‘brain-thyroid-lung syn-
drome’, and therefore very different from HD. These cases have
also been associated with loss of TITF-1-mediated striatal inter-
neurons.35 Given its more benign outcome, it is very important
to distinguish BHC from HD, although not always easy, due to
its variable expression. Less frequently than chorea, these
patients can manifest intention tremor, dysarthria, gait impair-
ment and exceptionally even psychosis, psychomotor develop-
mental problems and short stature.36 Albeit usually
non-progressive, the phenotype of BHC might change with
time, shifting from chorea to myoclonus and dystonia.37
Reduced striatal volumes on volumetric studies have also been
reported.38 However, genetic heterogeneity has been observed,
with two Japanese families expressing a similar phenotype but
with onset between ages 40 and 66, and for this reason resem-
bling adult-onset HD; these subjects, however, lacked cognitive
impairment and exhibited an association with a different locus
on chromosome 8q. This picture has been named BHC 2, and a
postmortem report in one of these patients surprisingly showed
pathological changes remarkably similar to those typical of pro-
gressive supranuclear palsy (neuroﬁbrillary tangles and tufted
astrocytes immunoreactive for four-repeat isoforms of τ).39
COGNITIVE AND BEHAVIOURAL FEATURES
Abnormalities of cognitive functioning and behaviour are car-
dinal features of HD. Classical, adult-onset HD is characterised
by a global, progressive cognitive decline. In early stages, cogni-
tive dysfunction may be subtle and detectable mainly through
formal neuropsychometry. It may present as loss of mental ﬂexi-
bility, executive dysfunction, memory difﬁculties (especially of
retrieval), and attention or concentration defects. Throughout
the course of illness, patients develop forgetfulness, bradyphre-
nia (ie, slowness of thought processes), impaired visuospatial
abilities and ability to manipulate knowledge, and language dis-
turbances leading to reduced syntactic complexity, cortical
speech problems, reduced word ﬁnding and paraphasic errors.
Psychopathology includes early personality changes, depression
(which may lead to increased suicidal ideation and suicide risk),
hostility, obsessive–compulsive symptoms, anxiety, heightened
interpersonal sensitivity and phobias. As disease progresses,
patients may exhibit affective or schizophrenic psychoses, par-
ticularly with paranoia delusions, as well as explosive and
aggressive outbursts, apathy, alcohol abuse, sexual dysfunction
and increased appetite.
A formal neuropsychometric and psychiatric assessment may
assist in the differential diagnosis in a minority of cases. Some
of the most common adult-onset progressive HD-like syndromes
are indistinguishable from HD in terms of their cognitive–
behavioural proﬁle. SCA17 leads to a fronto-subcortical demen-
tia in 75%–90% of cases, and to psychiatric symptoms very
similar to those in HD in 25%–30%.17 The choreatic form of
HDL2 presents with a cognitive–behavioural syndrome of
milder severity and slower progression, compared with HD and
to its Parkinsonian form, in which more severe fronto-
subcortical dementia, depression, apathy and irritability are
observed.3 HDL1, on the other hand, is characterised by a more
rapid progression of a similar cognitive dysfunction.32
A fronto-subcortical dementia is a cardinal feature of DRPLA,
present in 90% of patients, irrespective of their age at onset.
Although a psychiatric onset is rare, up to 80% of DRPLA
patients present with behavioural problems. Also, when the
onset of DRPLA occurs before the age of 20, we can detect
psychotic symptoms, hyperactivity/impulsivity, restlessness,
aggressive behaviours, autism-like features, and developmental
delay or regression.18
The cognitive–behavioural proﬁle of chorea-acanthocytosis is
very similar for course and phenomenology to that of classical
adult-onset HD, being characterised by a frontal lobe syndrome,
apathy, depression, bradyphrenia and obsessive–compulsive
symptoms, which are often subtle at onset. Memory impair-
ment, dysexecutive problems and a schizophreniform psychosis
may also occur at onset. Some additional features are, however,
typical of chorea-acanthocytosis, especially particular compul-
sive behaviours like trichotillomania, or self-mutilating actions
such as chronic head excoriations. Similarly severe, although at
an earlier age of onset, the persistent self-injurious behaviours
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of Lesch–Nyhan syndrome consist of biting of ﬁngers, hands,
lips and cheeks, and head- or limb-banging against hard objects.
Fronto-subcortical cognitive features are milder in McLeod syn-
drome, whereas psychiatric problems are very common, consist-
ing in personality disorder, anxiety, depression, obsessive–
compulsive disorder, and bipolar and schizoaffective disorder.
These psychiatric features may precede the movement disorder
by many years, whereas cognitive decline appears later in the
course of illness.
Juvenile HD differs from adult-onset HD in that it may
exhibit a more rapid and severe cognitive deterioration, asso-
ciated with speech and language delay. The intellectual impair-
ment observed in early onset dystonia/Parkinsonism syndromes,
such as PKAN, may be indistinguishable from that of juvenile
HD. Atypical forms of PKAN, which begin after the ﬁrst
decade, may be recognised, however, by some cognitive features.
Speech problems including palilalia, tachylalia/tachylogia and
dysarthria are frequent onset symptoms, which may be asso-
ciated with personality changes with impulsivity, violent out-
bursts, depression and emotional lability. Similar features can be
observed in all the main metal accumulation disorders resem-
bling juvenile HD, including PLAN, Kufor–Rakeb syndrome
and WD. In all these disorders, cognitive–behavioural abnormal-
ities become less severe as age of onset increases.
ANCILLARY INVESTIGATIONS
Basic ancillary investigations should be performed before any
genetic test in the diagnostic work-up of HD-like syndromes. A
number of routine blood tests are necessary to differentiate HD
from non-progressive causes of chorea. Most of these causes,
however, present with an acute or subacute onset, and therefore
display a very different course from heredodegenerative HD-like
syndromes. A detailed overview of these non-genetic choreas is
beyond the scope of this work and has been the object of other
review articles.40
Some laboratory tests are, however, useful also when facing a
clearly progressive hereditary HD-like syndrome. An increased
serum activity of creatine kinase and liver enzymes is frequently
observed in chorea-acanthocytosis and McLeod syndrome. Low
serum ferritin levels can be found in a proportion of patients
with neuroferritinopathy, whereas abnormal copper studies—
particularly increased 24 h urinary copper excretion—support a
diagnosis of WD, or aceruloplasminemia if ceruloplasmin is
undetectable in the serum. Abnormal lipoprotein electrophoresis
can be found in some patients with PKAN. Among autosomal
recessive ataxias, hypoalbuminemia is found in AOA type 1,
hypercholesterolaemia in both AOA types 1 and 2, whereas
increased serum levels of α-1-fetoprotein are found in AOA type
2 and AT.
Neuroacanthocytosis syndromes (chorea-acanthocytosis,
McLeod syndromes, HDL2, PKAN) are obviously characterised
by the presence of increased percentages of acanthocytes in the
peripheral blood. However, the determination of an increased
acanthocyte percentage in peripheral blood may not be sensitive
enough with routine traditional methods, and may require
phase contrast microscopy. An additional test that can be used
to identify patients with chorea-acanthocytosis is the demonstra-
tion of absent chorein expression in erythrocytes using western
blotting, but this test is not commercialised and is performed
only by very few laboratories in Europe and North America.11
Conventional brain MRI may be useful under certain circum-
stances. The typical adult-onset form of HD is characterised by
early striatal atrophy, particularly of the caudate, whereas a
certain degree of cortical and cerebellar atrophy may be seen
later on in the course of illness. Several adult-onset progressive
HD-like syndromes are indistinguishable from HD based on
MRI ﬁndings. Examples are HDL2, chorea-acanthocytosis and
McLeod syndrome. In the last two, the atrophy of the caudate is
accompanied by dilatation of the anterior horns of the lateral
ventricles, visible particularly on coronal sections, as often seen
also in HD.11 In addition, T2-weighted high signal lesions in the
striatum, mild generalised cortical atrophy (less in McLeod syn-
drome), and hippocampal sclerosis and atrophy (especially in
chorea-acanthocytosis) can be detected.31
The presence of cerebellar atrophy at various degrees is very
important to help differentiating HD from all forms of SCAs, in
particular SCA-17. MRI can be very useful to differentiate
DRPLA from HD, in that DRPLA patients exhibit cerebellar
and brainstem atrophy, particularly involving the pontine teg-
mentum, which correlates with age and number of
CAG-repeats;18 also, diffuse T2-weighted high signal lesions in
the deep subcortical white matter can be observed.41 Autosomal
recessive ataxias like FA, AOA types 1 and 2, and AT may not
exhibit cerebellar atrophy early in the course of illness.
However, FA may progress with atrophy of the cervical cord,
cerebellum and superior cerebellar peduncles,42 increased diffu-
sion in white matter tracts on diffusion-weighted imaging,43 and
reduced N-acetyl-aspartate peak height on magnetic resonance
spectroscopy.44 BHC, conversely, does not show pathological
changes on conventional imaging.
MRI can be of great use in guiding the differential diagnosis
between juvenile HD and metal accumulation disorders. PKAN
is associated with the pathognomonic ‘eye-of-the-tiger’ sign,
characterised by a central region of hyperintensity surrounded
by a rim of hypointensity on coronal or axial T2*-weighted
images in the globus pallidus.13 45 This abnormality is highly
correlated with the presence of PANK2 gene mutations, even in
the presymptomatic phase. Other brain metal accumulation dis-
orders, such as PLAN, Kufor–Rakeb syndrome, aceruloplasmi-
nemia (iron) and WD (copper) show mainly hypointense
pallidal signal without central hyperintensity and, less com-
monly, iron deposition in the substantia nigra, especially in
PLAN and Kufor–Rakeb syndrome. In NBIAs, typically, globus
pallidus and substantia nigra appear involved on T2* and fast
spin echo MRI scans, with also dentate involvement seen on
T2*-weighted images.
45 Interestingly, nigral pathology in PLAN
and Kufor–Rakeb syndrome seems related to the presence of a
PD-like Parkinsonism which responds to L-dopa, and may even
be complicated with L-dopa-induced dyskinesias.15 MRI,
however, may also be completely normal in these disorders.
Finally, other ancillary investigations provide limited add-
itional aid to the diagnostic work-up. The conﬁrmation of a
concurrent peripheral neuropathy or myopathy in
chorea-acanthocytosis or McLeod syndrome may require a
routine electromyographic or electroneurographic study. Evoked
potentials may be of some use to demonstrate degeneration of
posterior columns in spinocerebellar degenerative ataxias,
mainly SCA17 and FA. Muscle imaging, particularly CT, may
unveil fatty changes, associated with neurogenic atrophy on
biopsy, in patients with chorea-acanthocytosis and McLeod
syndrome.
CONCLUSIONS
The number of progressive heredodegenerative illnesses that
need to be considered in patients presenting with HD-like syn-
drome who tested negative for pathological IT15 gene
trinucleotide-repeat expansions has remarkably increased over
the next decade. The identiﬁcation of disease-causing variants in
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monogenic disorders is becoming increasingly powerful.
Methodologies such as exome sequencing, currently applied on
a limited basis, can provide speciﬁc genetic diagnoses also in
some HD-like syndromes, such as neuroacanthocytosis syn-
dromes,46 improving the potential of genotype–phenotype
studies. Genetic studies of these diseases remain in general,
however, very costly and not widely available in routine diag-
nostic laboratories. There is a substantial overlap in the clinical
phenotype of HD and HD-like syndromes, making the differen-
tial diagnosis between these different conditions difﬁcult in
several cases. However, a few clinical features, summarised in
the ﬂowchart in ﬁgure 1, can help clinicians to rationalise the
differential diagnosis, and avoid unnecessary expensive investi-
gations. These red ﬂags represent at present a simple guide that
should be constantly updated as the phenotypic characterisation
and the identiﬁcation of more reliable diagnostic markers for
HD-like syndromes progress over the following years. The list
of novel experimental treatment approaches for HD-like syn-
dromes is also growing.47–49 Further understanding of the
phenotype–genotype correlation of this heterogeneous group of
disorders will help patient selection and outcome prediction
with respect to new therapeutic strategies.
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